Takeda Pharmaceutical (TAK) Dividends Paid - Common (2018 - 2026)

Takeda Pharmaceutical's Dividends Paid - Common history runs 9 years deep, the most recent figure standing at $3.9 billion for Q1 2026.

• On a quarterly basis, Dividends Paid - Common changed 0.4% year-over-year to $3.9 billion in Q1 2026; TTM through Mar 2026 was $1.9 billion, a 5.54% decrease from a year earlier, with the FY2026 full-year figure at $2.1 billion, up 4.11% from the prior year.
• Dividends Paid - Common grew to $3.9 billion in Q1 2026 per TAK's latest filing, from -$968.4 million in the prior quarter.
• Across five years, Dividends Paid - Common topped out at $4.8 billion in Q1 2022 and bottomed at -$1.0 billion in Q2 2025.
• The 5-year median for Dividends Paid - Common is -$80.6 million (2022), against an average of $747.0 million.
• Biggest YoY gain for Dividends Paid - Common was 22.14% in 2023; the steepest drop was 13.71% in 2023.
• Year by year, Dividends Paid - Common stood at -$913.0 million in 2022, then declined by 2.44% to -$935.3 million in 2023, then declined by 2.29% to -$956.7 million in 2024, then slipped by 1.22% to -$968.4 million in 2025, then jumped by 504.97% to $3.9 billion in 2026.
• Per Business Quant, the three latest TAK Dividends Paid - Common figures stand at $3.9 billion (Q1 2026), -$968.4 million (Q4 2025), and -$59.6 million (Q3 2025).